Annual report on National Clinical Database 2020 for gastroenterological surgery in Japan [PDF]
Aim The National Clinical Database (NCD) of Japan is a nationwide data entry system for surgery, and it marked its 10th anniversary in 2020. The aim was to present the 2020 annual report of gastroenterological surgery of the NCD.
Yoshiki Kajiwara +24 more
doaj +3 more sources
Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan [PDF]
Aim The Japanese National Clinical Database, which covers more than 95% of the surgeries performed in Japan, is the largest nationwide database. This is the 2021 annual report of the Gastroenterological Section of the National Clinical Database, which ...
Sunao Ito +19 more
doaj +3 more sources
Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan [PDF]
Background Radical cystectomy (RC) is a standard‐of‐care treatment for muscle‐invasive bladder cancer (MIBC). However, there is a lack of data comparing the benefit of robot‐assisted radical cystectomy (RARC) with laparoscopic radical cystectomy (LRC) or
Shingo Hatakeyama +4 more
doaj +2 more sources
Trends in Gender Disparities in Surgical Experience: A National Clinical Database Study [PDF]
Background We previously reported the gender disparities in surgical procedures between male and female surgeons using National Clinical Database covering more than 95% of all operations performed in Japan.
Chie Tanaka +6 more
doaj +2 more sources
Annual Report of the 2022 National Clinical Database: Decade‐Long Trends and Current Status of Gastroenterological Surgery in Japan [PDF]
Aim The National Clinical Database (NCD) of Japan is the largest nationwide registry, covering over 95% of surgeries in the country. This 2022 annual report summarizes the short‐term outcomes of gastroenterological surgeries and discusses trends and ...
Koshi Kumagai +19 more
doaj +2 more sources
The clinical impact of COVID‐19 on endoscopic surgery in Japan: Analysis of data from the National Clinical Database [PDF]
Aim This study aimed to evaluate the impact of the coronavirus disease (COVID‐19) pandemic on elective endoscopic surgeries in Japan using the National Clinical Database.
Hidefumi Shiroshita +15 more
doaj +2 more sources
Effects of the COVID‐19 pandemic on gastroenterological surgeries in 2020: A study using the National Clinical Database of Japan [PDF]
Aim This study aimed to investigate the effect of the coronavirus disease pandemic on the number of surgeries for gastroenterological cancer cases in Japan.
Hiromichi Maeda +13 more
doaj +2 more sources
Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022 [PDF]
Aims We previously reported no change in surgical outcomes for laparoscopic distal gastrectomy (LDG) and laparoscopic low anterior resection (LLAR) early in the COVID‐19 pandemic (2020), although the number of elective surgeries decreased. In 2021, COVID‐
Masafumi Inomata +14 more
doaj +2 more sources
Influence of Facility Size on Perioperative Outcomes in Minimally Invasive Esophagectomy for 14 152 Patients With Esophageal Cancer Based on the Japanese National Clinical Database: A Multicenter Cohort Study [PDF]
Background Conventional minimally invasive esophagectomy (C‐MIE) is the mainstay for locally advanced esophageal cancer. However, the relationship among facility size, risk‐adjusted mortality and morbidity in C‐MIE remains unclear.
Taro Oshikiri +4 more
doaj +2 more sources
Risk factors for serious postoperative complications following gastrectomy in super‐elderly patients ≥85‐years‐old with gastric cancer: A National Clinical Database study in Japan [PDF]
Aim This study aimed to evaluate the technical safety and feasibility of gastrectomy for super‐elderly patients ≥85‐y‐old with gastric cancer and to clarify the risk factors for serious postoperative complications in these patients.
Yoshitake Ueda +10 more
doaj +2 more sources

